Asthma relievers – the new paradigm (RP August 2020)

Accredited CPD
Group 2

Provider: Retail Pharmacy
Author: Debbie Rigby


CPD Credits: 2

Overview 

Designed to give an overview of anti-inflammatory reliever therapy for patients with mild asthma.

Learning Objectives

After completing this activity, pharmacists should be able to:

  1. Describe the extent and consequences of over-reliance on short-acting bronchodilators in asthma
  2. Compare outcomes with anti-inflammatory relievers for patients with mild asthma
  3. Discuss with patients the benefits of anti-inflammatory reliever therapy for mild asthma

Competency Standards addressed (2016): 2.2, 3.2, 3.5.
Accreditation number: A2008RP2    Accreditation expires: 31/07/2022

This activity has been accredited for 1 hour of Group One CPD (or 1 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan, which may be converted to 1 hour of Group Two CPD (or 2.0 CPD credits) upon successful completion of the associated assessment activity.